Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic

Detalhes bibliográficos
Autor(a) principal: Bomfim, Amanda
Data de Publicação: 2023
Outros Autores: Rocha, Julie Souza de Medeiros, Grisi Júnior, Celso
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/40857
Resumo: Objective:  To describe the consumption profile of antidepressants and benzodiazepines in a Basic Health Unit in the Federal District before and during the COVID-19 Pandemic in order to observe the impact on the mental health of the population that uses this service. Methodology: This is a cross-sectional, descriptive study, with a retrospective analysis carried out by collecting data on the dispensing of antidepressants and benzodiazepines from a pharmacy in a Basic Health Unit Federal District. These data were collected from the psychotropic drug record book for the years 2019 to 2022. Results: An increase in the dispensation of antidepressants and benzodiazepines was observed in the years 2020, 2021 and 2022, pandemic years, when compared to year 2019.Conclusion: This study made it possible to visualize an increase in the consumption of some psychotropic drugs during the period of the COVID-19 pandemic, as a probable consequence of the increase in cases of psychological distress in the population served by a Basic Health Unit in the Federal District.
id UNIFEI_a2413499e3fa4750b930bcdc36ca06ee
oai_identifier_str oai:ojs.pkp.sfu.ca:article/40857
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 PandemicPerfil del consumo de antidepresivos y benzodiacepinas en una UBS del Distrito Federal durante la Pandemia del COVID-19Perfil do consumo de antidepressivos e benzodiazepínicos em uma UBS do Distrito Federal durante a Pandemia da COVID-19COVID-19 pandemicMental healthAntidepressantsHypnoticsSedatives.Pandemia COVID-19Saúde mentalAntidepressivosHipnóticosSedativos.Pandemia de COVID-19Salud mentalAntidepresivosHipnóticosSedantes.Objective:  To describe the consumption profile of antidepressants and benzodiazepines in a Basic Health Unit in the Federal District before and during the COVID-19 Pandemic in order to observe the impact on the mental health of the population that uses this service. Methodology: This is a cross-sectional, descriptive study, with a retrospective analysis carried out by collecting data on the dispensing of antidepressants and benzodiazepines from a pharmacy in a Basic Health Unit Federal District. These data were collected from the psychotropic drug record book for the years 2019 to 2022. Results: An increase in the dispensation of antidepressants and benzodiazepines was observed in the years 2020, 2021 and 2022, pandemic years, when compared to year 2019.Conclusion: This study made it possible to visualize an increase in the consumption of some psychotropic drugs during the period of the COVID-19 pandemic, as a probable consequence of the increase in cases of psychological distress in the population served by a Basic Health Unit in the Federal District.Objetivo: Describir el perfil de consumo de antidepresivos y benzodiazepinas en una Unidad Básica de Salud del Distrito Federal antes y durante la Pandemia del COVID-19 con el fin de observar el impacto en la salud mental de la población usuaria de este servicio. Metodología: Se trata de un estudio transversal, descriptivo, con análisis retrospectivo realizado mediante la recolección de datos sobre la dispensación de antidepresivos y benzodiazepinas de una farmacia en una Unidad Básica de Salud Distrito Federal. Estos datos fueron recolectados del libro registro de psicofármacos de los años 2019 a 2022. Resultados: Se observó un incremento en la dispensación de antidepresivos y benzodiazepinas en los años 2020, 2021 y 2022, años de pandemia, cuando en comparación con el año 2019. Conclusión: Este estudio permitió visualizar un aumento en el consumo de algunos psicofármacos durante el período de la Pandemia COVID-19, como probable consecuencia del aumento de casos de malestar psicológico en la población atendida por una Unidad Básica de Salud en el Distrito Federal.Objetivo: Descrever o perfil do consumo de antidepressivos e benzodiazepínicos de uma Unidade Básica de Saúde do Distrito Federal antes e durante a Pandemia da COVID-19, a fim de observar o impacto causado na saúde mental da população usuária deste serviço. Metodologia: Trata-se de um estudo transversal, descritivo, com análise retrospectiva realizado através da coleta de dados da dispensação de antidepressivos e benzodiazepínicos de uma farmácia em uma Unidade Básica de Saúde do Distrito Federal. Estes dados foram coletados do livro de registro de psicotrópicos referentes aos anos de 2019 a 2022. Resultados: Percebeu-se aumento na dispensação de antidepressivos e benzodiazepínicos nos anos de 2020, 2021 e 2022, anos pandêmicos, quando comparados ao ano de 2019. Conclusão: Este estudo permitiu visualizar aumento no consumo de medicamentos psicotrópicos no período da pandemia da COVID-19, como provável consequência do aumento dos casos de sofrimento psíquico na população atendida por uma Unidade Básica de Saúde do Distrito Federal.  Research, Society and Development2023-03-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4085710.33448/rsd-v12i3.40857Research, Society and Development; Vol. 12 No. 3; e28112340857Research, Society and Development; Vol. 12 Núm. 3; e28112340857Research, Society and Development; v. 12 n. 3; e281123408572525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/40857/33281Copyright (c) 2023 Amanda Bomfim; Julie Souza de Medeiros Rocha; Celso Grisi Júniorhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBomfim, AmandaRocha, Julie Souza de Medeiros Grisi Júnior, Celso 2023-03-23T08:33:38Zoai:ojs.pkp.sfu.ca:article/40857Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2023-03-23T08:33:38Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic
Perfil del consumo de antidepresivos y benzodiacepinas en una UBS del Distrito Federal durante la Pandemia del COVID-19
Perfil do consumo de antidepressivos e benzodiazepínicos em uma UBS do Distrito Federal durante a Pandemia da COVID-19
title Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic
spellingShingle Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic
Bomfim, Amanda
COVID-19 pandemic
Mental health
Antidepressants
Hypnotics
Sedatives.
Pandemia COVID-19
Saúde mental
Antidepressivos
Hipnóticos
Sedativos.
Pandemia de COVID-19
Salud mental
Antidepresivos
Hipnóticos
Sedantes.
title_short Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic
title_full Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic
title_fullStr Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic
title_full_unstemmed Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic
title_sort Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic
author Bomfim, Amanda
author_facet Bomfim, Amanda
Rocha, Julie Souza de Medeiros
Grisi Júnior, Celso
author_role author
author2 Rocha, Julie Souza de Medeiros
Grisi Júnior, Celso
author2_role author
author
dc.contributor.author.fl_str_mv Bomfim, Amanda
Rocha, Julie Souza de Medeiros
Grisi Júnior, Celso
dc.subject.por.fl_str_mv COVID-19 pandemic
Mental health
Antidepressants
Hypnotics
Sedatives.
Pandemia COVID-19
Saúde mental
Antidepressivos
Hipnóticos
Sedativos.
Pandemia de COVID-19
Salud mental
Antidepresivos
Hipnóticos
Sedantes.
topic COVID-19 pandemic
Mental health
Antidepressants
Hypnotics
Sedatives.
Pandemia COVID-19
Saúde mental
Antidepressivos
Hipnóticos
Sedativos.
Pandemia de COVID-19
Salud mental
Antidepresivos
Hipnóticos
Sedantes.
description Objective:  To describe the consumption profile of antidepressants and benzodiazepines in a Basic Health Unit in the Federal District before and during the COVID-19 Pandemic in order to observe the impact on the mental health of the population that uses this service. Methodology: This is a cross-sectional, descriptive study, with a retrospective analysis carried out by collecting data on the dispensing of antidepressants and benzodiazepines from a pharmacy in a Basic Health Unit Federal District. These data were collected from the psychotropic drug record book for the years 2019 to 2022. Results: An increase in the dispensation of antidepressants and benzodiazepines was observed in the years 2020, 2021 and 2022, pandemic years, when compared to year 2019.Conclusion: This study made it possible to visualize an increase in the consumption of some psychotropic drugs during the period of the COVID-19 pandemic, as a probable consequence of the increase in cases of psychological distress in the population served by a Basic Health Unit in the Federal District.
publishDate 2023
dc.date.none.fl_str_mv 2023-03-20
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/40857
10.33448/rsd-v12i3.40857
url https://rsdjournal.org/index.php/rsd/article/view/40857
identifier_str_mv 10.33448/rsd-v12i3.40857
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/40857/33281
dc.rights.driver.fl_str_mv Copyright (c) 2023 Amanda Bomfim; Julie Souza de Medeiros Rocha; Celso Grisi Júnior
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Amanda Bomfim; Julie Souza de Medeiros Rocha; Celso Grisi Júnior
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 12 No. 3; e28112340857
Research, Society and Development; Vol. 12 Núm. 3; e28112340857
Research, Society and Development; v. 12 n. 3; e28112340857
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052621195837440

Registros relacionados